If you dont drink enough water or eat enough, you wont be losing fat and you will gain the weight back after you stop using the drug. Remember to disclose your health history Because each medication is different, they can impact you differently based on your age, health conditions, and other medications you may be taking
Novo Nordisk (NVO): In 2023, Novo Nordisk announced the results from its SELECT trial that showed that semaglutide was associated with a 20% decreased risk of major adverse cardiac events comprised of cardiovascular death, nonfatal myocardial infarction (MI), and stroke compared with placebo in patients with overweight or obesity and established CVD but without diabetes
These factors contribute to better reproducibility in research and reduced variability in results
L-Carnitine & Carbohydrates Uptake is a very important consideration with carnitine, and a lot of research has shown that it is best absorbed when it is taken together with a large dose of carbs, 60-80g
Efficacy and Safety of GLP1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMA